Skip to content

Revvity RVTY Other Commercial Liabilities

Other Commercial Liabilities at other companies

Danaher logo
DanaherDHR
Illumina logo
IlluminaILMN
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Labcorp Holdings logo
Labcorp HoldingsLH
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's other commercial liabilities?
Revvity (RVTY) reported other commercial liabilities of $493.13M in Q1 2026.
How has Revvity's other commercial liabilities changed year-over-year?
Revvity's other commercial liabilities increased by 5.0% year-over-year, from $469.86M to $493.13M.
What is the long-term trend for Revvity's other commercial liabilities?
Over 5 years (2020 to 2025), Revvity's other commercial liabilities has grown at a -10.0% compound annual growth rate (CAGR), from $943.92M to $556.95M.